These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 29859237)
1. Comparison of arsenic methylation capacity and polymorphisms of arsenic methylation genes between bladder cancer and upper tract urothelial carcinoma. Huang CY; Lin YC; Shiue HS; Chen WJ; Su CT; Pu YS; Ao PL; Hsueh YM Toxicol Lett; 2018 Oct; 295():64-73. PubMed ID: 29859237 [TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of Arsenic (+3 Oxidation State) Methyltransferase and Arsenic Methylation Capacity Affect the Risk of Bladder Cancer. Lin YC; Chen WJ; Huang CY; Shiue HS; Su CT; Ao PL; Pu YS; Hsueh YM Toxicol Sci; 2018 Jul; 164(1):328-338. PubMed ID: 29669044 [TBL] [Abstract][Full Text] [Related]
3. Relation of polymorphism of arsenic metabolism genes to arsenic methylation capacity and developmental delay in preschool children in Taiwan. Hsieh RL; Su CT; Shiue HS; Chen WJ; Huang SR; Lin YC; Lin MI; Mu SC; Chen RJ; Hsueh YM Toxicol Appl Pharmacol; 2017 Apr; 321():37-47. PubMed ID: 28235556 [TBL] [Abstract][Full Text] [Related]
4. Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma. Chung CJ; Pu YS; Su CT; Huang CY; Hsueh YM Sci Total Environ; 2011 Jan; 409(3):465-70. PubMed ID: 21094982 [TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of human 8-oxoguanine DNA glycosylase 1 and 8-hydroxydeoxyguanosine increase susceptibility to arsenic methylation capacity-related urothelial carcinoma. Huang CY; Pu YS; Shiue HS; Chen WJ; Lin YC; Hsueh YM Arch Toxicol; 2016 Aug; 90(8):1917-27. PubMed ID: 26359225 [TBL] [Abstract][Full Text] [Related]
6. Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma. Huang SK; Chiu AW; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM Urol Int; 2009; 82(2):227-34. PubMed ID: 19322015 [TBL] [Abstract][Full Text] [Related]
7. AS3MT, GSTO, and PNP polymorphisms: impact on arsenic methylation and implications for disease susceptibility. Antonelli R; Shao K; Thomas DJ; Sams R; Cowden J Environ Res; 2014 Jul; 132():156-67. PubMed ID: 24792412 [TBL] [Abstract][Full Text] [Related]
8. Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma. Wu CC; Huang YK; Chung CJ; Huang CY; Pu YS; Shiue HS; Lai LA; Lin YC; Su CT; Hsueh YM Toxicol Appl Pharmacol; 2013 Oct; 272(1):30-6. PubMed ID: 23727622 [TBL] [Abstract][Full Text] [Related]
9. [Relationship between Arsenic (+3 Oxidation State) Methyltransferase Genetic Polymorphisms and Methylation Capacity of Inorganic Arsenic]. Agusa T; Kunito T; Minh Tue N; Thi Mai Lan V; Binh Minh T; Thi Kim Trang P; Fujihara J; Takeshita H; Takahashi S; Hung Viet P; Tanabe S; Iwata H Nihon Eiseigaku Zasshi; 2015; 70(3):186-96. PubMed ID: 26411936 [TBL] [Abstract][Full Text] [Related]
10. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer. Wang YH; Yeh SD; Wu MM; Liu CT; Shen CH; Shen KH; Pu YS; Hsu LI; Chiou HY; Chen CJ J Hazard Mater; 2013 Nov; 262():1139-46. PubMed ID: 23009795 [TBL] [Abstract][Full Text] [Related]
11. XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma. Chiang CI; Huang YL; Chen WJ; Shiue HS; Huang CY; Pu YS; Lin YC; Hsueh YM Toxicol Appl Pharmacol; 2014 Sep; 279(3):373-379. PubMed ID: 25018058 [TBL] [Abstract][Full Text] [Related]
12. The relationship between PNP, GSTO-1, AS3MT and ADRB3 gene polymorphisms and urinary arsenic concentration among copper smelter and refinery employers. Szymańska-Chabowska A; Matys T; Łaczmański Ł; Czerwińska K; Janus A; Smyk B; Mazur G; Poręba R; Gać P Hum Exp Toxicol; 2020 Nov; 39(11):1443-1453. PubMed ID: 32452228 [TBL] [Abstract][Full Text] [Related]
13. Significantly increased risk of carotid atherosclerosis with arsenic exposure and polymorphisms in arsenic metabolism genes. Hsieh YC; Lien LM; Chung WT; Hsieh FI; Hsieh PF; Wu MM; Tseng HP; Chiou HY; Chen CJ Environ Res; 2011 Aug; 111(6):804-10. PubMed ID: 21605854 [TBL] [Abstract][Full Text] [Related]
14. Genetic variants associated with arsenic susceptibility: study of purine nucleoside phosphorylase, arsenic (+3) methyltransferase, and glutathione S-transferase omega genes. De Chaudhuri S; Ghosh P; Sarma N; Majumdar P; Sau TJ; Basu S; Roychoudhury S; Ray K; Giri AK Environ Health Perspect; 2008 Apr; 116(4):501-5. PubMed ID: 18414634 [TBL] [Abstract][Full Text] [Related]
15. Association between arsenic (+3 oxidation state) methyltransferase gene polymorphisms and arsenic methylation capacity in rural residents of northern China: a cross-sectional study. Zhang M; Xu H; Lou Q; Zhang Z; Zhang X; Yin F; Lv M; Zhang Y; Yin Y; Gao Y; Liu X; Yang Y Arch Toxicol; 2023 Nov; 97(11):2919-2928. PubMed ID: 37658865 [TBL] [Abstract][Full Text] [Related]
16. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study. Huang YK; Huang YL; Hsueh YM; Yang MH; Wu MM; Chen SY; Hsu LI; Chen CJ Cancer Causes Control; 2008 Oct; 19(8):829-39. PubMed ID: 18351295 [TBL] [Abstract][Full Text] [Related]
17. Influence of AS3MT polymorphisms on arsenic metabolism and liver injury in APL patients treated with arsenic trioxide. Lu J; Yu K; Fan S; Liu W; Dong Z; Li J; Wang X; Hai X; Zhou J Toxicol Appl Pharmacol; 2019 Sep; 379():114687. PubMed ID: 31330140 [TBL] [Abstract][Full Text] [Related]
18. The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype. Chung CJ; Huang CY; Pu YS; Shiue HS; Su CT; Hsueh YM Toxicol Appl Pharmacol; 2013 Jan; 266(2):254-9. PubMed ID: 23159782 [TBL] [Abstract][Full Text] [Related]
19. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. Pu YS; Yang SM; Huang YK; Chung CJ; Huang SK; Chiu AW; Yang MH; Chen CJ; Hsueh YM Toxicol Appl Pharmacol; 2007 Jan; 218(2):99-106. PubMed ID: 17196235 [TBL] [Abstract][Full Text] [Related]
20. Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study. Beebe-Dimmer JL; Iyer PT; Nriagu JO; Keele GR; Mehta S; Meliker JR; Lange EM; Schwartz AG; Zuhlke KA; Schottenfeld D; Cooney KA Environ Health; 2012 Jun; 11():43. PubMed ID: 22747749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]